Meta AnalysisID 343

补充红曲米对代谢综合征的影响:一项系统评价与Meta分析

CRD42020209186

Is red yeast rice supplementation improve metabolic syndrome?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Herb: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
343
Evidence Id
8901
Core Evidence Id
8901
Source Meta Analysis Id
323
Herb2 Meta Analysis Id
HBMA000323
Crd Id
CRD42020209186
Title
The effect of red yeast rice supplementation on metabolic syndrome: a systematic review andmeta-analysis
Review Question
Is red yeast rice supplementation improve metabolic syndrome?
Study Type Included
Inclusion criteria: Randomized controlled trial (RCT), controlled trial, clinical trial, randomized trial. Exclusion criteria: Case report, case series, review, animal experiments.
Condition Being Studied
metabolic syndrome
Participant
Inclusion criteria: Patients were included if they had metabolic syndrome and the components of the syndrome: elevated fasting plasma glucose, triglycerides, HDL-cholesterol, blood pressure and waist circumference, regardless of their age, sex, or nationality. The diagnostic criteria for metabolic syndrome should have met at least one of the international or domestic guidelines. Exclusion criteria: Patients were excluded if they had acute myocardial infarction, severe arrhythmia, heart failure, hepatic failure, renal failure, or acute infection.
Animal
Human Disease Modelled
Intervention
Inclusion criteria: Studies including the use of red yeast rice or xuezhikang (plus any or no other intervention) in metabolic syndrome. No limitations on blinding, dosage or treatment duration. If an add-on study design was applied, patients in the treatment group should have been treated with the same type and dosage of conventional therapy under the same standard as was used in the control group. Exclusion criteria: Studies not including the use of red yeast rice or xuezhikang in metabolic syndrome treatment.
Comparator Control
Inclusion criteria: All comparators (placebo, no intervention or conventional therapy) will be accepted. Exclusion criteria: Studies not including a comparator.
Main Outcome
triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), blood pressure (BP), blood glucose, waist circumference. Measures of effect odds ratios
Outcome Measure
Additional Outcome
serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), Body Mass Index (BMI), impaired glucose tolerance, HbA1c%, fasting insulin, insulin resistance index (HOMA-IR), cardiovascular events, adverse events. Measures of effect odds ratios, relative risks.
Study Method
Meta-analysis, Systematic review
Keyword
Biological Products; Dietary Supplements; Humans; Metabolic Syndrome; red yeast rice
Contact
Rong Yuan [email protected]
Organisational Affiliation
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Funding Source
No
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2020-09-14
Registration Date
2020-10-15
Anticipated Start Date
2020-09-07
Anticipated Completion Date
2020-12-31
Title Cn
补充红曲米对代谢综合征的影响:一项系统评价与Meta分析
Title En
The effect of red yeast rice supplementation on metabolic syndrome: a systematic review andmeta-analysis
Bilingual Status
complete